# Analgesia After Total Shoulder Arthroplasty

> **NCT01782872** · PHASE4 · COMPLETED · sponsor: **Hospital for Special Surgery, New York** · enrollment: 80 (actual)

## Conditions studied

- Total Shoulder Arthroplasty

## Interventions

- **PROCEDURE:** Interscalene Block (ISB) - 0.375% Ropivacaine + additives
- **PROCEDURE:** Interscalene Block (ISB) - 0.2% Ropivacaine + additives
- **PROCEDURE:** Interscalene Block (ISB) - 0.1% Ropivacaine + additives
- **PROCEDURE:** Interscalene Block (ISB) - Systemic Control

## Key facts

- **NCT ID:** NCT01782872
- **Lead sponsor:** Hospital for Special Surgery, New York
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2014-01
- **Final completion:** 2014-02
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2016-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01782872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01782872, "Analgesia After Total Shoulder Arthroplasty". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01782872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*